Ownership history in Bridgefront Capital, LLC · 10 quarters on record
This page tracks every 13F SEC filing in which Bridgefront Capital, LLC reported a position in AMICUS THERAPEUTICS INC (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 24,418 | -25,483 | -51.1% | 0.06% | $192K | $7.88 |
| 2025 Q2 | REDUCED | 49,901 | -619 | -1.2% | 0.08% | $286K | $5.73 |
| 2025 Q1 | ADDED | 50,520 | +2,780 | +5.8% | 0.12% | $412K | $8.16 |
| 2024 Q4 | ADDED | 47,740 | +11,042 | +30.1% | 0.15% | $450K | $9.42 |
| 2024 Q3 | ADDED | 36,698 | +25,715 | +234.1% | 0.15% | $392K | $10.68 |
| 2024 Q2 | REDUCED | 10,983 | -2,139 | -16.3% | 0.05% | $109K | $9.92 |
| 2023 Q1 | ADDED | 13,122 | +481 | +3.8% | 0.09% | $146K | $11.09 |
| 2021 Q2 | REDUCED | 12,641 | -16,739 | -57.0% | 0.05% | $122K | $9.64 |
| 2021 Q1 | ADDED | 29,380 | +13,040 | +79.8% | 0.09% | $290K | $9.88 |
| 2020 Q4 | INITIATED | 16,340 | — | — | 0.13% | $377K | $23.09 |
As of 2025 Q4 — sorted by position size